New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis

Clin Infect Dis. 2008 Dec 15;47(12):1587-92. doi: 10.1086/593310.

Abstract

Twenty years of global polio eradication efforts may soon eliminate the transmission of wild-type poliovirus. However, new information that has been learned about poliovirus, as well as the political realities of a modern world, demand that universal immunity against poliomyelitis be maintained, even after wild-type poliovirus is eradicated. Although 2 excellent vaccines have proven to be highly effective in the past, neither the live-attenuated vaccine nor the currently used inactivated vaccine are optimal for use in the posteradication era. Therefore, concerted efforts are urgently needed to develop a new generation of vaccine that is risk-free and affordable and can be produced on a global scale. Here, we discuss the desired properties of a vaccine and methods to create a new polio vaccine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Humans
  • Poliomyelitis / prevention & control*
  • Poliovirus Vaccine, Inactivated / immunology*

Substances

  • Poliovirus Vaccine, Inactivated